Medifast

American multi-level marketing company

MED NYSE ISIN US58470H1014 SEC CIK 910329 LEI 5299000YHQJ21T5KKI80
Follow Medifast Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $72M −19.4% vs same quarter last year
Net income −$17.5M −674.5% vs same quarter last year
EPS, diluted −$1.57 −647.6% vs same quarter last year
Operating cash flow $3.3M −72.8% vs same quarter last year
Revenue by quarter
$119M
$115.7M
$105.6M
$89.4M
$75.1M
$76M
$76.4M
$72M
Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income15 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5B$2BFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearRevenueNet income
FY25$385.8M−$19M
FY24$602.5M$2M
FY23$1.1B$99M
FY22$1.6B$144M
FY21$1.5B$164M
FY20$934.8M$102.9M
FY19$713.7M$77.9M
FY18$501M$55.8M
FY17$301.6M$27.7M
FY16$274.5M$17.8M
FY15$272.8M$20.1M
FY14$285.3M$13.2M
FY13$324.1M$24M
FY12$318.6M$15.9M
FY11$298.2M$18.5M
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−25%0%25%50%75%100%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2571.3%−3.7%−4.9%
FY2473.8%0.5%0.3%
FY2372.4%11.8%9.2%
FY2271.3%11.6%9%
FY2173.9%14.2%10.7%
FY2074.6%14.4%11%
FY1975.2%12.8%10.9%
FY1875.8%13.8%11.1%
FY1775.5%13.1%9.2%
FY1674.9%9.8%6.5%
FY1573.8%10.5%7.4%
FY1473.3%10.6%4.6%
FY1374.2%11.9%7.4%
FY1274.1%8.5%5%
FY1175.3%9.2%6.2%
Free cash flowOperating cash flow minus capital expenditure
$0$50M$100M$150M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearFree cash flow
FY25$1.2M
FY24$17M
FY23$141.2M
FY22$177.9M
FY21$60.3M
FY20$139.3M
FY19$74.2M
FY18$55.9M
FY17$40M
FY16$22.5M
FY15$26.6M
FY14$18.5M
FY13$31M
FY12$32.1M
FY11$20.6M
Returned to shareholdersDividends paid and shares bought back
  • Dividends
  • Buybacks
$0$50M$100M$150M$200MFY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearDividendsBuybacks
FY25$195K$0
FY24$715K$0
FY23$73M$3.6M
FY22$71.6M$126.4M
FY21$63.9M$56M
FY20$53.2M$5M
FY19$35.4M$33.1M
FY18$23.2M$30M
FY17$15.4M-
FY16$11.9M-
FY15-$10.5M
FY14-$33.9M
FY13-$20.1M
FY12-$2.8M
FY11-$20.4M
Net margin vs the sectorMedian of Consumer companies filing with the SEC
  • Medifast
  • Consumer median
−5%0%5%10%15%FY11FY13FY15FY17FY19FY21FY23FY25
Show the numbers
YearMedifastConsumer median
FY25−4.9%1.1%
FY240.3%1.5%
FY239.2%2.1%
FY229%2.5%
FY2110.7%2.5%
FY2011%1.8%
FY1910.9%2.6%
FY1811.1%3.8%
FY179.2%3.8%
FY166.5%4.3%
FY157.4%3.8%
FY144.6%3.6%
FY137.4%3.9%
FY125%4.1%
FY116.2%2.9%